Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...
New research suggests the disease begins working silently long before the first clear symptoms.
A simple blood test into multiple sclerosis (MS) pathology could speed MS diagnostics and ultimately improve patient care, according to Xiaoli Yu, Ph.D., senior author of a new study on plasma ...
Share on Pinterest Scientists are trying to find blood biomarkers that may help predict the course of disease in MS. Betsie Van der Meer/Getty Images As of 2020, about 2.8 million people globally have ...
A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
Collaboration enables patients to access the Octave MSDA test at Quest’s approximately 7,000 patient access sites across the U.S. and establishes a pathway to introduce additional tests from Octave’s ...
An estimated 2.8 million people worldwide have multiple sclerosis (MS). This autoimmune condition is the result of the immune system damaging parts of the nerves in the brain and spinal cord, which ...
A new blood test may be the first reliable way to predict whether a person will develop the debilitating nerve disease multiple sclerosis (MS). The test, which takes just two days, could speed up ...
Neurological autoimmune diseases happen when the immune system attacks the central nervous system (CNS) or peripheral nervous system (PNS). This can cause neurological symptoms, and about 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results